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ARTICLE
Helical antimicrobial peptides assemble into
protofibril scaffolds that present ordered dsDNA to
TLR9
Ernest Y. Lee 1, Changsheng Zhang2,5, Jeremy Di Domizio 3, Fan Jin 4, Will Connell1, Mandy Hung1,
Nicolas Malkoff1, Veronica Veksler1, Michel Gilliet3, Pengyu Ren 2 & Gerard C.L. Wong1
Amphiphilicity in ɑ-helical antimicrobial peptides (AMPs) is recognized as a signature of
potential membrane activity. Some AMPs are also strongly immunomodulatory: LL37-DNA
complexes potently amplify Toll-like receptor 9 (TLR9) activation in immune cells and
exacerbate autoimmune diseases. The rules governing this proinflammatory activity of AMPs
are unknown. Here we examine the supramolecular structures formed between DNA and
three prototypical AMPs using small angle X-ray scattering and molecular modeling. We
correlate these structures to their ability to activate TLR9 and show that a key criterion is the
AMP’s ability to assemble into superhelical protofibril scaffolds. These structures enforce
spatially-periodic DNA organization in nanocrystalline immunocomplexes that trigger strong
recognition by TLR9, which is conventionally known to bind single DNA ligands. We
demonstrate that we can “knock in” this ability for TLR9 amplification in membrane-active
AMP mutants, which suggests the existence of tradeoffs between membrane permeating
activity and immunomodulatory activity in AMP sequences.
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Antimicrobial peptides (AMPs) are multifunctional mole-cules important for host defense1. Many AMPs areamphiphilic ɑ-helices (AaHs), and can kill pathogens by
permeating membranes and inhibiting intracellular processes1–3.
However, evidence indicates that AMPs can also be immuno-
modulatory, inducing cytokine production, chemoattraction, and
immune cell differentiation4–7. Recently, it has been shown that
AMPs can modulate Toll-like receptor (TLR) activation by
endogenous and microbial immune ligands such as lipopoly-
saccharide8 and nucleic acids like DNA and RNA9, and that
complex formation between AMPs and immune ligands may be
important. Normal expression of AMPs results in immunosti-
mulation that potentially synergizes with direct antimicrobial
activity in immune responses to microbial invasion, but aberrant
expression of AMPs can lead to uncontrolled inflammation in
autoimmune diseases like systemic lupus erythematosus and
psoriasis10–15. Specifically, modulation of TLR9 signaling in
plasmacytoid dendritic cells (pDCs) leads to amplification of type
I interferon (IFN) production, which drives disease progression4.
In a more general compass, although ɑ-helical motifs are com-
mon, only a small subset exhibits this proinflammatory activity.
At present, we do not know the fundamental rules governing how
ɑ-helical motifs assemble with immune ligands like DNA into
structural states that enable TLR9 modulation.
In a parallel development, there has been significant interest in
understanding the programmed assembly of chemically patchy,
anisotropic objects into structures beyond the well-known
amphiphilic assembly of surfactants into micelles16. Janus parti-
cles are nanoparticles with surfaces that have two or more distinct
properties that can be changed by varying the material or surface
chemistry, which modulate the particle’s local charge, hydro-
phobicity, dipole moment, and polarizability. The inherent
asymmetry in the surface properties of these particles leads to
complex effects such as the self-assembly of colloids with direc-
tional bonding17 and programmed assembly of Janus particles
into a Kagome lattice18. Machine learning on particle tracking
data of Janus particles reveals unique self-assembly pathways
involving formation of clusters, chains, and pinwheels19.
Assembly of peptides into fibrils has long been a hallmark of
amyloid diseases20, and recently self-assembly of peptide
amphiphiles into ordered structures has been shown to be
important for regenerative medicine21,22. For assembling units
with more complex geometry than surfactants, shape and che-
mical heterogeneity can exact competing demands on the
assembly process and lead to counterintuitive results23. Even
without the complications from amphiphilic self-assembly,
cationic globular molecules and anionic biological polyelec-
trolytes are known to order into columnar electrostatic complexes
with structural polymorphism24–26. Although AMPs are known
to aggregate under certain conditions27, it is not clear from the
perspective of self-assembly of anisotropic Janus objects how
curved, cationic AaHs will electrostatically assemble with anionic
DNA, much less how the geometry of the resultant self-assembled
AaH-DNA structures connect to their immunomodulatory
behavior. Elucidation of these structures is complicated by the
fact that immunologically relevant complexes tend to be small
enough for endocytosis (<~200 nm as measured by dynamic light
scattering) and weakly ordered due to their macromolecular
nature, hence not optimal for crystallography.
Here we examine the structures of immunologically active
complexes formed between DNA and three prototypical ɑ-helical
AMPs (melittin, LL37, and buforin) and related mutants from the
perspective of Janus self-assembly using a combination of syn-
chrotron small-angle X-ray scattering (SAXS) and molecular
modeling. By correlating these structures to IFN production by
human pDCs and by mouse macrophages, we find that a key
criterion is the Janus peptide’s ability to function as subunits that
assemble into superhelical protofibrils with hydrophobic cores in
the presence of DNA, which is possible with curved but not
straight helices. In order to maximize the entropy gain of coun-
terion release, these cationic coiled-coil protofibrils interact with
anionic DNA to form columnar protofibril-DNA nanocrystals.
These AMP-DNA complexes are then internalized into the
endosomes of immune cells like macrophages and dendritic cells
and are strongly recognized by TLR928. TLR9 is conventionally
thought to bind single naked double-stranded DNA (dsDNA)
ligands29. However, we find that periodic aggregates of nano-
crystalline DNA ligands scaffolded by AMPs amplify TLR9-
mediated inflammation by enhancing TLR9 recruitment and
binding through multivalent effects. The formation of such AaH-
DNA nanocrystals explains how AMPs can organize DNA into
spatial periodicities that match the steric size of TLR928,30, which
is not possible without higher-order protofibril self-assembly.
Interestingly, the AaH protofibrils can adapt their helical pitch to
optimize binding: protofibrils of melittin and those of LL37 have
pitches that differ by a factor of ~2, in order to preserve the same
density of positive charges for optimal DNA charge compensa-
tion. Using AMPs melittin, LL37, and buforin, we show how AaH
hydrophobicity impacts protofibril self-assembly, which track
with the level of TLR9 activation. Interestingly, melittin-related
peptides with systematic reduction of membrane remodeling
activity measured with SAXS led to a progressive increase of
TLR9-activating ability. These observations suggest that the
requirements for membrane activity and immunomodulation via
TLR activation, two canonical functions of AMPs which both
require a facially amphiphilic helix architecture, are overlapping
but clearly distinct. Taken together, these results provide insight
into trade-offs between membrane activity and immunomodu-
latory activity in AMPs.
Results
Selection of ɑ-helical AMPs. To understand dsDNA condensa-
tion and immune stimulation by AaH, we selected three proto-
typical AMPs. LL37 is an ɑ-helical AMP and has been previously
shown to enable immune activation in lupus and psoriasis by
forming complexes with dsDNA10,11,13. LL37 (+6 charge at pH
7.4) is a low-symmetry object; it has a curved amphipathic helix-
bend-helix motif with a glycine at position 14. We hypothesized
curved ɑ-helices with compensating cationic charge density and
amphipathicity may assemble into a macromolecular scaffold to
organize dsDNA. We chose melittin and buforin as direct com-
parisons to LL37 since they are amphiphilic but have different
charge densities and hydrophobicities, with little sequence simi-
larity. Full details of peptide selection and sequence analysis are
found in the Supplementary Discussion. Using these AMPs, we
correlate self-assembled AMP-dsDNA structures with their ability
to activate TLR9.
Melittin organizes dsDNA into a tetragonal lattice. We inves-
tigate the structure of melittin-dsDNA complexes using a com-
bination of SAXS and molecular modeling. From SAXS, we find
that solubilized DNA alone does not form ordered structures
(Supplementary Figure 1). In contrast, melittin-DNA forms a
three-dimensional (3D) tetragonal lattice with Bragg reflections at
q100= 0.173, q001= 0.215, q110= 0.244, q111= 0.308, q200=
0.345, q210= 0.386, q211= 0.429, q112= 0.454, q220= 0.492,
q300= 0.518, q003= 0.577, and q320= 0.622 Å−1 (Fig. 1a, b). The
lattice parameters are d= 3.64 nm and c= 3.28 nm (Fig. 1c,
Supplementary Table 1). This indicates that the inter-dsDNA
spacing between parallel dsDNA rods is 3.64 nm. The out-of-
plane parameter indicates that the complex has additional order
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along the dsDNA axis, with a spacing of c= 3.28 nm. The
melittin monomer (Fig. 1d) has a diameter of ~1.2 nm. The inter-
dsDNA spacing of 3.64 nm is larger than that expected from a
single melittin molecule at bridging or centered high-symmetry
sites (Fig. 1e). To better understand why this occurs, we con-
ducted molecular simulations on the self-assembly of melittin.
Since other AMPs have been shown to self-assemble into diverse
nanostructures27, we hypothesized that melittin can self-assemble
into a cationic coiled-coil protofibril in the presence of anionic
dsDNA. Starting from the nuclear magnetic resonance monomer
structure of melittin (PDB: 2MLT_A), we modeled a 26mer of
melittin self-assembled into a protofibril using TINKER and the
AMBER force field (Fig. 2a, Supplementary Methods, Supple-
mentary Figures 2, 3, 4). We obtained an optimized monomer
structure within the melittin protofibril. The protofibril has a
cross-sectional dimension of 2.7 nm × 2.7 nm, with a pitch
between monomers of 0.82 nm (~3.28 nm per turn). Melittin
packs into a four-fold symmetric protofibril with hydrophobic
residues in the interior, and cationic residues exposed to the
exterior. We constructed an 8 × 8 square lattice of dsDNA rods
with the energy-minimized melittin superhelices (Fig. 2b, c).
CRYSOL was used in an iterative process to refine the molecular
model of the melittin-dsDNA lattice structure based on the SAXS
data. Calculated diffraction peak positions from the energy-
minimized structure (Fig. 2b, c) reproduce the scattering peaks
seen in the experimental SAXS data (q100= 0.168, q001= 0.204,
q110= 0.246, q111= 0.302, q200= 0.344, q210= 0.384, q211=
0.431, q112= 0.457, q220= 0.497, q300= 0.525, q003= 0.578, and
q320= 0.621 Å−1) (Fig. 2d). Formation of the AMP protofibril
makes the large observed inter-dsDNA spacing possible in
melittin-dsDNA complexes.
LL37 organizes dsDNA into a two-dimensional columnar
square lattice. LL37 is a human ɑ-helical AMP that kills bacteria by
forming pores in their cell membranes31. However, LL37 is also
central to the pathogenesis of autoimmune diseases13. Whereas
melittin has a proline kink, LL37 has a glycine kink. The isoelectric
LL37-dsDNA complex forms a two-dimensional (2D) square
columnar lattice with Bragg reflections at q10= 0.182, q11= 0.258,
q12= 0.419, q22= 0.529, and q23= 0.680 Å−1, corresponding to a
lattice parameter of d= 3.40 nm (Fig. 3a, b, Supplementary
Table 1). This indicates that the spacing between parallel dsDNA
rods is 3.40 nm in this complex. However, the diameter of LL37 is
~1.2 nm (Fig. 3c), which is too small to explain the observed inter-
dsDNA spacing from SAXS. X-ray analysis of the LL37-DNA
complex in human serum yields a similar result (Supplementary
Figure 5). We hypothesize that LL37 assembles into a cationic
protofibril that interacts with anionic DNA to form a square
columnar lattice (Fig. 3d). We conducted molecular dynamics
simulations in a similar manner to the melittin-dsDNA complex to
develop a physical model of LL37 self-assembly (Supplemen-
tary Methods, Supplementary Figures 2, 3, 4). Starting from the
crystal structure of LL37 (PDB: 2K6O), we optimized the structure
of an LL37 26mer with multiple rounds of energy minimization and
molecular simulation. The final protofibril structure yields four
LL37 per helix turn, with a pitch of 6.8 nm and cross section of
2.5 nm × 2.5 nm (Fig. 3e). Similar to melittin, the curved,
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Fig. 1 Small-angle X-ray scattering (SAXS) structure of melittin-double-stranded DNA (dsDNA) complexes. a Representative SAXS data of an isoelectric
melittin-dsDNA complex with the first Bragg peak q100 indicated. b The magnified data region shows details of diffraction features qhkl, which index well to a
three-dimensional tetragonal lattice. c To obtain the lattice parameters, we fit the measured Bragg peak positions to predicted reflections using multiple
linear regression. The lattice parameters of the melittin-dsDNA complex are d= 3.64 nm and c= 3.28 nm (R2= 0.999). d Structure of the melittin
monomer (PDB: 2MLT_A57). Cationic residues are colored blue, hydrophobic residues are colored white, and polar uncharged residues are colored green.
e Schematic of parallel dsDNA rods within the melittin-dsDNA tetragonal lattice labeled with lattice parameters obtained from SAXS. The average domain
size of the melittin-dsDNA lattice is L ~ 62.4 nm
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amphipathic nature of LL37 allows for favorable interactions
between the hydrophobic faces of adjacent LL37 in the interior of
the protofibril, allowing for outward exposure of the cationic resi-
dues on opposite faces. The cationic backbone of the protofibril can
then coordinate four dsDNA rods simultaneously, forming a square
lattice. Next, we create a full LL37-dsDNA square lattice model by
superimposing 3 × 3 dsDNA rods coordinated with multiple LL37
protofibrils (Fig. 3f). We observe that the LL37-dsDNA lattice from
simulation has an inter-dsDNA spacing of 3.40 nm, which agrees
well with the measured value from SAXS. Using CRYSOL, we
observe good correspondence between the major peaks observed in
the SAXS diffraction spectrum and the predicted peaks from the
atomic structure of simulated lattice (q10= 0.181, q11= 0.257,
q12= 0.413, q22= 0.523, and q23= 0.666Å−1) (Fig. 3g). Note that
although a 3D LL37-DNA tetragonal lattice was predicted based on
molecular modeling, a cognate 2D square lattice at the same inter-
DNA spacings was observed experimentally, likely due to weaker
ordering along the protofibril axis compared to the in-plane
ordering. Furthermore, we studied effects of various structural
parameters on the diffraction pattern. We varied the direction
distribution of the AMP superhelices (helical axis C-to-N vs. helical
axis N-to-C) and the phase distribution of protofibrils in the lattice
(rotation around the superhelical axis). We found that for both the
LL37-dsDNA and melittin-dsDNA complexes, these parameters do
not strongly impact the observed inter-dsDNA spacing, indicating
that these structures are likely at equilibrium.
Buforin condenses dsDNA into a disordered columnar struc-
ture. To determine whether the size of the hydrophobic face
influences the formation of square columnar DNA lattices with
the optimal inter-DNA spacing for TLR9 activation, we chose to
study buforin. Compared to melittin and LL37, buforin has
similar net charge and charge density, but has a much smaller
hydrophobic face (~80°). Unlike LL37 and melittin, buforin is not
a full ɑ-helix. The helical portion distal to the proline kink is a
random coil. Instead of exhibiting well-defined diffraction peaks
that index to a 2D columnar lattice, SAXS data from buforin-
dsDNA complexes revealed a single diffraction feature at q1=
0.170 Å−1 with weaker broad scattering at higher q, consistent
with a disordered or amorphous structure with an estimated
inter-dsDNA spacing of d= 3.70 nm (Fig. 4a). This result is
interesting since buforin has sufficient charge density to condense
DNA. Since buforin has a hydrophobic face that subtends <90°
(Fig. 4b), we hypothesized that it cannot stabilize the 360°
hydrophobic core in a protofibril with four-fold coordinated
helices due to suboptimal interior hydrophobic interactions.
Instead, buforin likely forms multimers with various coordination
numbers (e.g. 3–5) that give dsDNA columnar lattices with short-
ranged order (Fig. 4c).
AMP-dsDNA complexes amplify inflammation by binding to
TLR9. To investigate the ability of melittin-, LL37-, and buforin-
dsDNA complexes to activate TLR9, we incubated pre-mixed
AMP-dsDNA complexes with murine wild-type (WT) and TLR9-
knockout (TLR9KO) macrophages and measured subsequent
IFN-β production (Fig. 5a). In a parallel assay, we also stimulated
TLR9-expressing human pDCs in the absence and presence of
chloroquine and measured subsequent IFN-ɑ production
(Fig. 5b). LL37 and buforin were mixed with mouse genomic
dsDNA (mdsDNA) in the macrophage experiments and human
genomic dsDNA (hdsDNA) in the pDC experiments. Melittin
was unable to induce cytokine production because it was highly
cytotoxic to immune cells, consistent with previous observations
from the literature32 (Supplementary Figure 6). In both assays, we
observed significant levels of TLR9-dependent type I IFN pro-
duction in response to both LL37-dsDNA (p < 0.01 macrophage,
p < 0.05 pDC) and buforin-dsDNA complexes (p < 0.05 macro-
phage, p < 0.05 pDC) (Fig. 5a, b). In the murine macrophage
system, both complexes produced IFN levels comparable to or
greater than stimulation with lipopolysaccharide (LPS; TLR4
agonist) or ODN 1826 (TLR9 agonist). No significant activation
was observed by peptides alone or mdsDNA alone. In the human
pDC system, both LL37-dsDNA and buforin-dsDNA complexes
produced significant TLR9-dependent IFN production compared
to controls. The presence of 1 μM chloroquine, an endosomal
acidification inhibitor, abrogates all TLR9-dependent signaling.
These data confirm that both LL37 and buforin drive immune cell
activation in a TLR9-dependent manner. Genomic dsDNA by
itself is non-immunogenic, but complexation with AMPs enables
breakdown of immune tolerance10. The consistency in results
between the murine and human systems suggests that this phe-
nomenon is general and reinforces the idea that the crystallinity
of these AMP-dsDNA complexes are important determinants
governing amplified TLR9 activation. We observed that the
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Fig. 2 Structure of melittin-double-stranded DNA (dsDNA) complexes
from molecular simulations. a Side and top views of the melittin protofibril
self-assembled in the presence of dsDNA. The cross-sectional dimensions
of the protofibril is 2.7 nm × 2.7 nm. The helical pitch of the protofibril is
3.28 nm per turn. Top (b) and side (c) views of an 8 × 8 melittin-dsDNA
square lattice from molecular dynamics simulations. Columnar dsDNA is
colored red, and the melittin protofibril is colored green (N to C terminus
polarity) and teal (C to N terminus polarity). Random polarity of the melittin
protofibril is assumed. The inter-dsDNA spacing from the molecular model
obtained from simulation is d= 3.64 nm, which agrees well with the
predicted inter-dsDNA spacing from small-angle X-ray scattering (SAXS).
The out-of-plane lattice parameter of c= 3.28 nm also agrees with the
simulated pitch of the melittin protofibril. d There is good agreement
between the observed structure factor peaks from SAXS with peaks
recovered from theoretical X-ray scattering of the lattice model in b and
c from CRYSOL58
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LL37-dsDNA complex activates 3–5× more strongly than the
buforin-dsDNA complex. The average domain size for the
ordered LL37-dsDNA nanocrystalline complex is 16.1 nm,
whereas buforin-dsDNA complexes are disordered, with an esti-
mated domain size of 4.3 nm. Note that SAXS measurements are
performed on precipitated nanocrystals, and that domain sizes
will be limited by the size of the nanocrystalline complexes. These
observations on complexes that activate TLR9 are consistent with
the conjecture that more crystalline complexes (e.g. well-ordered
complexes with defined inter-DNA spacings and a larger number
of DNA ligands) lead to greater potential TLR9 activation due to
multivalent binding to TLR9.
Trade-offs in AMP immunomodulatory and membrane activity.
The observation that melittin has poor IFN-inducing abilities via
TLR9 is an intriguing one, especially since melittin-dsDNA com-
plexes exhibit an optimal inter-dsDNA spacing similar to that of the
LL37-dsDNA complex and exhibit good crystallinity (domain size
~ 62.4 nm). Both melittin and LL37 facilitate self-assembly into a
protofibril in the presence of dsDNA (Figs. 1–3). However, the
hydrophobic face of melittin (~180°) is larger than that of LL37
(~120°); such increased degrees of hydrophobicity in AMPs often
correspond to increased nonspecific membrane activity. In the
present context, this is not inconsistent with the increased toxicity
of melittin to immune cells relative to that of LL3733.
To better understand the complex relationship between
membrane activity, dsDNA-binding, and TLR9 activation by ɑ-
helical AMPs, we selected three melittin-inspired peptides to
study, AR23, RV23, and MM1, in addition to melittin itself. AR23
and RV23 are 23-amino acid ɑ-helical structural analogs of
melittin, with both containing a proline hinge similar to melittin.
Both AR23 and RV23 possess reduced hemolytic and cytotoxic
activity compared to melittin34,35, and have either reduced charge
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Fig. 3 Structure of LL37-double-stranded DNA (dsDNA) complexes from small-angle X-ray scattering (SAXS) and molecular simulations. a Representative
SAXS data from an isoelectric LL37-dsDNA complex. All observed reflections are labeled with their respective Miller indices (hk). b Two-dimensional
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h2 þ k2p , yielding a lattice parameter of d= 3.40 nm (R2= 0.999). c Structure of the LL37
monomer (PDB: 2K6O59). Cationic residues are colored in blue and hydrophobic residues are colored in white. d Schematic of the LL37-dsDNA square
columnar lattice with an inter-dsDNA spacing of d= 3.40 nm. The average domain size of the LL37-dsDNA lattice is L ~ 16.1 nm. e Side and top views of the
self-assembled LL37 protofibril structure formed in the presence of dsDNA. The protofibril has rough cross-sectional dimensions of 2.5 nm × 2.5 nm. The
helical pitch of the protofibril is 6.8 nm per turn. f Top view of a 3 × 3 LL37-dsDNA square lattice from molecular dynamics simulations. Columnar dsDNA is
colored red, and the LL37 protofibril is colored green (N to C terminus polarity) and teal (C to N terminus polarity). Random polarity of the LL37 protofibril
is assumed. The inter-dsDNA spacing from the molecular model is 3.4 nm, which agrees with the inter-dsDNA spacing predicted from SAXS. g There is
good agreement between the observed structure factor peaks from SAXS with peaks recovered from theoretical X-ray scattering of the lattice model in
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Fig. 4 Structure of buforin-double-stranded DNA (dsDNA) complexes.
a Representative small-angle X-ray scattering (SAXS) data of an isoelectric
buforin-dsDNA complex. One main diffraction peak is observed at q1=
0.170 Å−1 with weak broad features at higher q, consistent with a
disordered columnar structure with short-ranged order. b Structure of the
buforin monomer (taken from the H2A histone, PDB: 4KGC60). See
Supplementary Discussion for details regarding the relationship between
buforin and H2A. c Illustration of the buforin-dsDNA columnar lattice with
average inter-dsDNA spacing of d= 3.70 nm
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or reduced overall hydrophobicity, respectively. MM1 is a
melittin point mutant with several modified amino acids,
including removal of the proline hinge and reduced overall
hydrophobicity. Melittin, AR23, RV23, and MM1 were incubated
with PS/PE= 20/80 model membranes and the induced negative
Gaussian curvature (NGC), the type of curvature topologically
required for membrane permeation36–42, was measured using
SAXS (Fig. 6a, c). In separate experiments, AMP-dsDNA
complexes using the peptides were solved using SAXS (Fig. 6b).
The TLR9-activating abilities of the AMP-dsDNA complexes
were determined via immune stimulation experiments with
human pDCs (Fig. 6d).
Melittin, AR23, and RV23 induced cubic phases rich in NGC in
model membranes, as evidenced by peaks satisfying the Pn3m q-
ratios of √2:√3:√4:√6:√8:√9 (Fig. 6a). In contrast, MM1 did not
induce cubic phases (membrane only controls are shown in
Supplementary Figure 7). The quantity of NGC induced by the
peptides in identical membranes is calculated from the lattice
parameters (a) of the Pn3m cubic phases measured, according to
the formula ⧼k⧽= 2πχ/A0a2 (χ=−2 and A0= 1.919 for Pn3m).
Melittin generated the largest amount of NGC ⧼kmelittin⧽=
−2.75 × 10−2 nm−2, corresponding to a lattice parameter of
amelittin= 15.4 nm. In contrast, AR23 and RV23 induced reduced
quantitative amounts of NGC from the same membranes, with
⧼kAR23⧽=−1.85 × 10−2 nm−2 and ⧼kRV23⧽=−1.18 × 10−2 nm−2
(Fig. 6c, fits in Supplementary Figure 8). Thus, melittin, AR23,
RV23, and MM1 are representative examples of ɑ-helical AMPs
that span a range of membrane remodeling ability, with melittin
being the strongest and MM1 being the weakest.
To determine whether the differences in charge and hydro-
phobicity of melittin-related AMPs affected their ability to bind to
DNA, we measured the structures of AR23-, RV23-, and MM1-
DNA complexes with SAXS and compared them to the structure
of the melittin-DNA complex (Fig. 6b, fits in Supplementary
Figure 9, Supplementary Table 1) (melittin-DNA SAXS data are
reproduced from Fig. 1 for clarity). AR23 and RV23 form square
columnar lattices with dsDNA, in a similar manner to melittin
and LL37 (Figs. 1–3). AR23-DNA and RV23-DNA complexes
exhibit inter-DNA spacings (dAR23= 3.78 nm, dRV23= 3.87 nm)
similar to melittin-DNA (dmelittin= 3.64 nm) and slightly larger
than LL37-DNA (dLL37= 3.40 nm) but still in the activating range
(Supplementary Table 1). This indicates that despite amino-acid
changes leading to reduced membrane activity, AR23 and RV23
retain the ability to organize DNA into a four-fold square
lattice. In contrast, MM1-DNA forms a disordered structure with
short-ranged order (Fig. 6b). MM1-DNA complexes exhibit
more disorder than melittin-, AR23-, RV23-, and LL37-DNA
complexes, and have a significantly larger inter-DNA spacing
(dMM1= 4.19 nm).
Based on these measured inter-DNA spacings, we would
predict that AR23-DNA and RV23-DNA complexes possess the
ability to induce TLR9-mediated inflammation in pDCs, while
MM1 would not. The above complexes were incubated with
human pDCs and resulting IFN-ɑ production was measured
(Fig. 6d). As expected, AR23- and RV23-DNA complexes both
induced greater IFN-ɑ production from pDCs compared to both
melittin and MM1-DNA complexes. Interestingly, the increase in
TLR9-activating ability in AR23 and RV23 relative to melittin
negatively correlates with induced NGC in cell membranes
(Fig. 6c, d). For peptides that have conserved DNA-binding and
square lattice-forming activity (AR23 and RV23), systematic
reduction of NGC-inducing ability corresponds to a recovery in
ability to induce IFN-ɑ from pDCs. MM1, however, is not only
unable to organize DNA into a square lattice with an inter-DNA
spacing in the optimal range but also unable to induce NGC. This
is consistent with mutational changes in its sequence that lead to
dual abolishment of membrane activity and DNA-binding/TLR9-
activating ability. Taken together, these findings suggest that the
physiochemical requirements for membrane activity and dsDNA-
binding/TLR9 activation of ɑ-helical AMPs are overlapping but
distinct. Moreover, trade-offs between these two channels of
activity in a given AMP sequence are possible.
Discussion
One central question is how the existence of these peptide-
dsDNA complexes relate to disease states. LL37-DNA complexes
are found in vivo in patients with systemic lupus erythemato-
sus11. These complexes are formed extracellularly during
inflammation and neutrophil cell death (NETosis), and are
internalized into phagocytic immune cells, which trigger pro-
duction of proinflammatory cytokines via TLR9 activation. Fur-
thermore, the presence of LL37-DNA complexes in the serum of
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lupus patients correlates with increased cytokine production and
induce production of autoantibodies to DNA and to AMPs.
LL37-mitochondrial DNA complexes were found to be enriched
in plasma and atherosclerotic plaques in a mouse model of
atherosclerosis; such complexes were also found to induce TLR9-
mediated inflammatory responses43. Other examples of AMP-
DNA complexes relevant to inflammation in autoimmune dis-
eases include IL-26-DNA complexes44,45 as well as hBD2-DNA,
hBD3-DNA, and lysozyme-DNA complexes12. Thus, AMP-DNA
complexes are clearly relevant to autoimmune and inflammatory
diseases. What is unknown is how complexes between AaHs and
dsDNA impact immune outcomes.
AaHs are broadly recognized as membrane-binding peptides.
While it has been known that AMPs can be immunomodulatory,
it has only been recently discovered that ɑ-helical amphiphilic
AMPs form immunologically active complexes with immune
ligands9,28. In the above experiments, we show that low-
symmetry Janus objects such as curved AaHs can self-organize
into ordered chaperone protofibrils (cognate to amyloid fibrils46)
that nucleate the assembly of dsDNA immune ligands into
ordered nanocrystalline complexes with well-defined inter-ligand
spacings, which in turn amplify cytokine secretion via multivalent
binding to TLR9.
In the systems considered here, electrostatic and hydrophobic
effects amplify Janus assembly. Clearly, AaHs have too small of a
steric diameter to organize the required proinflammatory inter-
DNA distances (~3.6 nm) in a given DNA-AaH complex.
Aggregation of amphiphiles into spherical micelles is a common
mode of assembly, and aggregation of Janus objects with various
types of patchiness into complex assemblies has also been well-
documented16,18. Here the Janus assembly of AaH into four-fold
coordinated superhelical protofibrils is driven in part by the
creation of an appropriate cationic surface charge density to
compensate the anionic charge density of DNA; this effect is
pivotal for generating the macromolecular structures optimal for
TLR9 activation. In this context, a comparison between melittin
and LL37 peptides is telling. Both peptides are amphiphilic and
have 35–40% hydrophobic residues (Supplementary Table 2). On
the hydrophilic face of the two peptides, the density of the
positive-charged residues (lysine or arginine) along the axis are 21
per 3.4 nm (Supplementary Table 3), which matches well to the
negative charge density of DNA, 20 per 3.4 nm. This charge
compensation allows for maximal entropy gain from counterion
release upon binding47. Interestingly, melittin has no negatively
charged residues while LL37 has ~1.5 e− per 3.4 nm. The nega-
tively charged residues in LL37 contribute to the stabilization of
its long helix and will interact with cations (such as Na+) in the
AMP/DNA lattice. The electrostatic potential surface of melittin
and LL37 peptides do not show significant differences as both are
dominated by the well-exposed positive residues (Supplementary
Figure 10). That the superhelical protofibril architecture can
modify its pitch to accommodate AMP subunits with different
charge distributions suggests a soft torsional modulus and flexible
mechanism of assembly, reminiscent of other forms of electro-
static assembly between macroions48. The ability to assemble in
this specific manner and the concomitant ability to amplify innate
immune responses place constraints on the cationic amino-acid
placement, hydrophobic content, and geometric morphology of
the constituent AaH. (For example, straight AaHs cannot
assemble into protofibrils in this way, so the central glycine in
LL37 and proline in melittin are important).
Coming full circle to the canonical function of membrane-
active AMPs, it is interesting to compare the structural require-
ments for membrane permeation and those for immunomodu-
lation via the specific pathway of DNA-binding and TLR9. Our
results above suggest that there are trade-offs between the two in
a given AMP sequence. Melittin, which is conventionally thought
of as a toxin rather than an AMP due to its low selectivity for
microbial vs host membranes, forms ordered lattices with DNA,
similar to LL37. However, melittin-DNA complexes cannot
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appreciably induce TLR9 activation despite having a similar inter-
DNA spacing to LL37-DNA. By studying melittin mutants and
analogs, we find that we can progressively knock in the ability for
TLR9 amplification by detuning the melittin sequence away from
maximal generation of NGC necessary for membrane permea-
tion. This has implications for the molecular design of multi-
functional peptides that are both antimicrobial and
immunomodulatory49,50.
An understanding of the rules for immunomodulation by
peptides can be broadly enabling. Here we show using several
prototypical AMPs how AaHs can assemble DNA into an
immunoactive nanocrystalline complex that amplifies the TLR9
pathway and illustrate governing rules for this process via AaH
sequences capable of different quantitative degrees of immune
modulation. From our recent work on TLR3 activation by
nanocrystalline AMP-dsRNA complexes9, it will not be surprising
that more general rules exist.
Methods
Preparation of self-assembled peptide-dsDNA complexes. Lyophilized peptides
LL37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES), melittin (GIGA-
VLKVLTTGLPALISWIKRKRQQ), buforin (TRSSRAGLQFPVGRVHRLLRK),
MM1 (GIGAVLKALTTGLGALASAIKRKRQQ), AR23 (AIGSILGA-
LAKGLPTLISWIKNR), and RV23 (RIGVLLARLPKLFSLFKLMGKKV) were pur-
chased from Anaspec or Lifetein (≥95% purity by high-performance liquid
chromatography (HPLC)) and dissolved in nuclease-free water (Ambion) to 10 mg
mL−1. For SAXS experiments, monodispersed Lambda dsDNA (New England
BioLabs) or Escherichia coli genomic dsDNA (Affymetrix) was precipitated and
resuspended in 100 mM NaCl+ 10 mM HEPES (pH 7.4) to 5 mgmL−1. For cell
experiments, endotoxin-free human (hdsDNA) and mouse (mdsDNA) genomic
self-dsDNA were purchased (Biochain) and used without further purification.
Peptide-dsDNA complexes were formed by incubating the peptide with dsDNA
(1–5 mgmL−1 for SAXS experiments and 10–20 μg mL−1 for cell experiments) at
specific peptide-to-dsDNA charge ratios (P/dsDNA= 1:4, 1:2, 1:1, 2:1, 4:1). For a
particular peptide, the same charge ratios were used in both SAXS and cell
experiments. For some experiments, complexes were mixed in the presence of
human serum (Sigma-Aldrich, H4522).
SAXS experiments with peptide-dsDNA complexes. We measured the struc-
tural phase diagram of the structures of peptide-dsDNA complexes by incubating
peptides (10 mgmL−1) with dsDNA (5mgmL−1) at specific charge ratios in
microcentrifuge tubes. After thorough mixing and centrifugation, precipitated
complexes are hermetically sealed in 1.5 mm quartz capillaries (Hilgenberg GmbH,
Mark-tubes). SAXS experiments were performed at Stanford Synchrotron Radia-
tion Lightsource (SSRL, Beamline 4-2) using monochromatic X-rays with an
energy of 9 keV. A Rayonix-MX225-HE detector (pixel size 73.2 μm) was used to
measure the scattered radiation. Independent identical samples were prepared and
measured over multiple time points to ensure consistency. 2D powder diffraction
patterns were integrated using the Nika 1.7451 package for Igor Pro 6.37 and
FIT2D52. SAXS data were analyzed by plotting integrated scattering intensity
against the momentum transfer q using Mathematica. Peak positions were mea-
sured by fitting diffraction peaks to a Lorentzian. Structures of complexes were
solved by calculating ratios between the q-positions of all measured peaks and
comparing them with the permitted reflections for specific structures. The lattice
parameter(s) of each phase were calculated by linear regression through points
corresponding to measured and theoretical peaks. The lattice parameter d indicates
the inter-dsDNA spacing between dsDNA columns. For a square columnar lattice,
qhk ¼ 2πd
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
h2 þ k2p . For a tetragonal columnar lattice, qhkl ¼ 2π
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
h2þk2
d2 þ l
2
c2
q
, where c
is the out-of-plane lattice parameter along the dsDNA axis. For a columnar lattice
with short-ranged order, the inter-dsDNA spacing a is estimated from the first
peak position by the formula d= 2π/q1.
Domain size calculations. To calculate the domain size of the nanocrystalline self-
assembled polycation-dsDNA complex, we fitted the first Bragg peak of each SAXS
spectrum. From this, we obtained the peak width, the average domain size (L), and
the number of repeat units (m) in each complex. To obtain the domain size, we
approximated the structure factor peaks as squared-Lorentzians. The form of the
equation used for the fit was
S qð Þ ¼ h
3
4π q q1j j2þ h2
 2 2
where q1 is the location of the first peak and h is the peak width28. The experi-
mental SAXS data were background-subtracted, and the first peak for each complex
was fitted using nonlinear least-squares regression in Mathematica. The extracted
value for peak width h can be related to the average linear domain size L using
Warren’s approximation53. The domain size is related to h via the equation54
L ¼ 8πð Þ
1
2
h
2
We assume that a typical bundle has an area proportional to L2. To calculate the
number of repeat units in each complex m, we estimated this by dividing the linear
domain size L by the measured inter-dsDNA spacings d (m= L/d).
Diffraction from disordered anisotropic systems can in principle be complex.
We consider disordered bundles as follows. The occurrence of a single broad
diffraction feature in S(q) suggests a disordered system with short-ranged
exponential decay of positional correlations. Here S(q) has a Lorentzian form. After
powder averaging over all solid angles, we approximate the domain size as:
L ¼ 2
1
2
h
2
Macrophage stimulation experiments. To validate the ability of peptide-dsDNA
complexes to activate TLR9, we stimulated WT and TLR9KO BL6 mouse mac-
rophages in vitro and measured subsequent IFN-β production using a Luciferase
Bio-ELISA. Peptide-dsDNA complexes were generated as described above, using
mouse genomic self-dsDNA. Complexes were incubated at room temperature prior
to stimulation. Complexes were generated by mixing 2 μg of mdsDNA (BioChain)
with 10 μg of peptides (e.g. LL37 or buforin) in 40 μL of nuclease-free water
(Ambion) and then diluted into 200 μL of media for cell stimulation (final con-
centrations: 10 μg mL−1 mdsDNA and 50 μg mL−1 peptide).
Positive controls for IFN production include a TLR9-positive control (ODN
1826, Invivogen, 10 μgmL−1) and a TLR4-positive control (LPS, Sigma-Aldrich, 200
pgmL−1). Negative controls included the peptides alone and genomic dsDNA alone
at the same concentrations as used for the immune complex stimulations (Fig. 5b).
WT and TLR9KO macrophages were grown to confluency in RPMI+ bovine
growth serum (BGS)+ penicillin/streptomycin (Pen/Strep)+ L-glutamine (Gibco),
washed, and seeded into 96-well microplates with a final concentration of 105 cells
per well. Complexes were added to WT and TLR9KO cells, diluted to a final
volume of 150 μL, and incubated at 37 °C for 10 h. Supernatants were removed and
frozen at −80 °C overnight. All stimulations were done in triplicate.
IFN-β bioassay. IFN-β bioassay was carried out similarly to prior work55.
Supernatants were assayed for type I IFN production (IFN-β) using ISRE-L929 IFN
reporter cells (Bio-ELISA system with IFN-β receptor coupled to a luciferase
promoter). ISRE-L929 cells were grown to confluency in RPMI+ BGS+ Pen/
Strep+ L-glutamine and plated to a final concentration of 105 cells per well in a 96-
well microplate. Fifty microliters of supernatant was incubated with ISRE-L929
cells for 7 h at 37 °C. An eight-point standard curve with twofold serial dilutions of
known IFN-β concentrations (R&D Systems) was incubated with ISRE-L929 cells
at the same time. ISRE-L929 cells are lysed overnight at −80 °C in Passive Lysis
Buffer (Promega). Luciferase production in ISRE-L929 is quantified using a Luci-
ferase Assay System (Promega) with a luminometer plate reader (Biotek). Luci-
ferase production was converted to IFN-β production using the calibrated IFN-β
standard curve. Peptide-dsDNA complexes that induce a TLR9-specific response
produce a significantly larger amount of IFN-β from WT stimulation compared to
TLR9KO stimulation (unpaired Student’s t-test).
Lactate dehydrogenase cell death assay. Cytotoxicity of peptides against WT
and TLR9KO bone-marrow-derived macrophages were measured using a lactate
dehydrogenase (LDH) release assay kit (Promega). Macrophages were grown to
confluency in RPMI 1640+ BGS+ Pen/Strep+ L-glutamine (Gibco), washed, and
seeded into 96-well microplates with a final concentration of 105 cells per well.
Cells with stimulated by peptide-DNA complexes for 10 h, and the supernatant was
removed for LDH quantification. Fifty microliters of supernatant was placed into a
fresh 96-well clear-bottom plate, 50 μL of LDH substrate mix was added, and the
plate was incubated at room temperature for 2 min under foil. Fifty microliters of
stop solution was added, and the plate was centrifuged briefly to remove air
bubbles. The plate absorbance was read at 490 nm and LDH release was quantified
relative to a maximum lysis control.
pDC stimulation experiments. Blood buffy coats of healthy donors were obtained
from the Interregionale Blutspende SRK, Bern, Switzerland. Peripheral blood
mononuclear cells were obtained by Ficoll centrifugation of blood buffy coats.
pDCs were then isolated by magnetic separation using the Diamond pDC Isolation
kit II (Miltenyi). Purified pDCs were cultured in 96-well round-bottom plates at
5 × 104 per well in 200 μL RPMI 1640 (GIBCO) supplemented with 10% fetal calf
serum (Atlanta Biologicals) and Pen/Strep in the presence of LL37-hdsDNA or
buforin-hdsDNA complexes. LL37-hdsDNA and buforin-hdsDNA complexes were
generated by mixing 2 μg of hdsDNA (BioChain) with 10 μg of LL37 or buforin in
40 μL of nuclease-free water (Ambion) and then diluted into 200 μL of complete
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medium for cell stimulation (final concentrations: 10 μg mL−1 hdsDNA and 50 μg
mL−1 LL37 or buforin). In some instances, pDCs were pre-incubated with 1 μM
chloroquine diphosphate (Sigma) for 15 min before stimulation. The different
supernatants were collected after overnight culture and the levels of type I IFN
production were measured by enzyme-linked immunosorbent assay (ELISA;
human IFN-α pan, Mabtech).
SAXS experiments with model membranes. Peptides were purchased (Anaspec,
Lifetein) and synthesized in high purity ( >95% HPLC) using solid-phase synthesis.
Liposomes were prepared as previously described elsewhere56. Lyophilized DOPS
(1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt)) and DOPE (1,2-dio-
leoyl-sn-glycero-3-phosphoethanolamine) from Avanti Polar Lipids were used.
Stock solutions were dissolved in chloroform at 20 mgmL−1. Mixtures of these
lipids were used as a first-order model for bacterial membranes. DOPS and DOPE
were mixed at a 1:4 molar ratio (DOPS/DOPE= 20/80). Chloroform was evapo-
rated under N2, and the lipids were further dried overnight under vacuum. Dried
lipids were resuspended in 100 mM NaCl+ 10 mM HEPES at pH 7.4 to a final
concentration of 20 mgmL−1. Aqueous lipid solutions were incubated overnight at
37 °C. Liposomes were prepared by sonication of resuspended lipids until clear.
Monodispersity in size was obtained via extrusion through a 0.2 μm filter.
Before use, peptides are solubilized in nuclease-free pure water. Liposomes
(DOPS/DOPE= 20/80) and peptides were mixed at a peptide-to-lipid charge ratio
(P/L) of 1/2 and equilibrated at room temperature overnight. Precipitated peptide-
lipid complexes were loaded into 1.5 mm glass quartz capillaries (Mark-tubes,
Hilgenberg GmbH) and hermetically sealed. SAXS experiments were conducted at
the Stanford Synchrotron Radiation Laboratory (BL 4–2) with monochromatic X-
rays of energy 9 keV. Scattered radiation was collected using a Rayonix-MX225-HE
detector (pixel size 73.2 μm). The 2D diffraction patterns were integrated using the
Nika 1.7451 package for Igor Pro 6.37 (Wavemetrics) and FIT2D52. For all samples,
multiple measurements were taken for consistency. Samples were incubated at
37 °C and centrifuged at 6000 RPM for 20 min before measurement. No changes
were observed over multiple experiments and exposures.
SAXS data were analyzed by plotting the integrated scattering intensity I(q) vs. q
using Mathematica. To determine the phases present in each sample, the measured
peak positions were obtained and their ratios were compared to the permitted
reflections for different liquid-crystalline lipid phases (e.g. lamellar, inverse
hexagonal, and cubic). Membrane curvature-generating ability of the peptides was
determined by calculating the lattice parameter a for the measured cubic phases.
Cubic phases observed in our experiments belonged to the Pn3m space group.
Measured q positions for the Bragg peak reflections were fitted to the equation
qmeasured= 2π√(h2+ k2+ l2)/a where (hkl) are the Miller indices. The quantity of
induced NGC was calculated as the average NGC per unit cell volume using the
equation ⧼k⧽= 2πχ/A0a2, where χ is the Euler characteristic and A0 is the surface
area per cubic unit cell for each phase. Parameter values are χ=−2 and A0= 1.919
for Pn3m.
Statistical analyses. Analysis of all immune stimulation data was done in
Mathematica using pairwise two-tailed t-tests with a significance level of α= 0.05.
Code availability. Code for molecular modeling will be provided upon reasonable
request.
Data availability
Data supporting the findings of this study are available within the Article and its
Supplementary Information files and from the corresponding authors upon reasonable
request.
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